Cargando…
Whole-Blood 3-Gene Signature as a Decision Aid for Rifapentine-based Tuberculosis Preventive Therapy( )
BACKGROUND: Systemic drug reaction (SDR) is a major safety concern with weekly rifapentine plus isoniazid for 12 doses (3HP) for latent tuberculosis infection (LTBI). Identifying SDR predictors and at-risk participants before treatment can improve cost-effectiveness of the LTBI program. METHODS: We...
Autores principales: | Huang, Hung Ling, Lee, Jung Yu, Lo, Yu Shu, Liu, I Hsin, Huang, Sing Han, Huang, Yu Wei, Lee, Meng Rui, Lee, Chih Hsin, Cheng, Meng Hsuan, Lu, Po Liang, Wang, Jann Yuan, Yang, Jinn Moon, Chong, Inn Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477448/ https://www.ncbi.nlm.nih.gov/pubmed/34989801 http://dx.doi.org/10.1093/cid/ciac003 |
Ejemplares similares
-
Impact of Age on Outcome of Rifapentine-Based Weekly Therapy for Latent Tuberculosis Infection
por: Huang, Hung-Ling, et al.
Publicado: (2020) -
Subsequent Antituberculous Treatment May Not Be Mandatory Among Surgically Resected Culture-Negative Pulmonary Granulomas: A Retrospective Nationwide Multicenter Cohort Study
por: Chung, Che-Liang, et al.
Publicado: (2021) -
CoMI: consensus mutual information for tissue-specific gene signatures
por: Huang, Sing-Han, et al.
Publicado: (2022) -
Reply to Chang and Huang
por: Huang, Hung-Ling, et al.
Publicado: (2022) -
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
por: Mathad, Jyoti S, et al.
Publicado: (2021)